April 27, 2024
Transluminal Angioplasty: why was Dotter’s disruptive innovation initially rejected?

Transluminal Angioplasty: why was Dotter’s disruptive innovation initially rejected?

Transluminal Angioplasty: why was Dotter’s disruptive innovation initially rejected?

Video by PCR via YouTube
Go to Source
Transluminal Angioplasty: why was Dotter’s disruptive innovation initially rejected?

Voices from the past, messages to build the future: Episode #2
In this second episode, Chiara De Biase and Jean Marco highlight three key reasons for Charles Dotter’s failure to spread his method widely in the USA. Firstly, his position as a radiologist, not a vascular surgeon; secondly, his aggressive presentation of the technique, coupled with limited patient data; and lastly, his unconventional approach to developing tools and the lack of clear objectives.
Stay tuned to discover how Dotter’s method made its way to Europe in the next episode.

More about the history of angioplasty on PCRonline: https://www.pcronline.com/About-PCR/40-years-angioplasty

#interventionalcardiology #MedicalHistory #CharlesDotter #TransluminalAngioplasty

Go to Source